Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials

✍ Scribed by Schoenfeld, P.; Pimentel, M.; Chang, L.; Lembo, A.; Chey, W. D.; Yu, J.; Paterson, C.; Bortey, E.; Forbes, W. P.

• Book ID: 121664771
• Publisher: John Wiley and Sons
• Year: 2014
• Tongue: English
• Weight: 129 KB
• Volume: 39
• Category: Article
• ISSN: 0269-2813
• DOI: 10.1111/apt.12735